author-photo

Bruce Randazzo

Janssen Pharmaceutica
University of Pennsylvania

57

Papers

2252

Citations

Citation Trend

Filter By

Papers (57) Sort By

JournalConferenceOthers

Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study.

2021 Journal of Dermatological Treatment
Show All
- Source
- Cite
- Save
Citations (0)
15302 Psoriasis area and severity index component improvements at week 48 in patients treated with guselkumab compared with secukinumab: Findings from the ECLIPSE study

2020 Journal of The American Academy of Dermatology
Show All
- Source
- Cite
- Save
Citations (0)
15188 Clinical responses by self-reported PsA status at baseline among patients with moderate to severe psoriasis treated with guselkumab versus secukinumab: Week 48 results from the ECLIPSE study

2020 Journal of The American Academy of Dermatology
Show All
- Source
- Cite
- Save
Citations (0)
15277 Malignancy rates and comparisons to the general US population through 3 years of follow-up in guselkumab-treated patients with moderate to severe psoriasis from the VOYAGE 1 and 2 trials

2020 Journal of The American Academy of Dermatology
Show All
- Source
- Cite
- Save
Citations (0)
Extrapolating Pharmacodynamic Effects from Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients with Moderate to Severe Plaque Psoriasis.

2020 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (2)
Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in pediatric patients (≥6 to <12 years of age): efficacy, safety, pharmacokinetic, and biomarker results from the open‐label CADMUS Jr study

2020 British Journal of Dermatology
Show All
- Source
- Cite
- Save
Citations (12)
Amélioration du score PASI absolu chez des patients atteints de psoriasis traités par le guselkumab ou le sécukinumab: résultats de l’étude ECLIPSE

2019 Annales De Dermatologie Et De Venereologie
Show All
- Source
- Cite
- Save
Citations (0)
SAT0390 GUSELKUMAB WAS MORE EFFECTIVE THAN SECUKINUMAB IN PATIENTS WITH PLAQUE PSORIASIS AND THE SUBSET OF PATIENTS WITH SELF-REPORTED PSORIATIC ARTHRITIS IN THE RANDOMIZED, DOUBLE-BLIND, HEAD-TO-HEAD COMPARISON STUDY ECLIPSE OVER 1 YEAR

2019 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Constance de la réponse selon les caractéristiques de sévérité de la maladie chez les patients atteints de psoriasis modéré à sévère traités par le guselkumab par rapport au sécukinumab : résultats de l’étude ECLIPSE à la semaine 48

2019 Annales De Dermatologie Et De Venereologie
Show All
- Source
- Cite
- Save
Citations (0)
Constance de la réponse selon l’âge chez des patients atteints de psoriasis modéré à sévère traités par guselkumab vs sécukinumab : résultats de l’étude ECLIPSE à la 48e semaine

2019 Annales De Dermatologie Et De Venereologie
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号